2014 Annual Shareholder Meeting

Dwight Babcock, CEO

Brien Ragle Bill Cavanagh

Dale Boyce Krista Cline

Herb Barbosa Clay OLaughlin

BRAIN

HEAD and NECK

LUNG

PROSTATE

GYNECOLOGY

1st Peer reviews Published1st Prostate Patient Reaches the 10 Year Mark1stStereotactic Brain Treatment Peru Child1stRussian Prostate Implants Performed1stLiquid Cs-131 GliaSite Case Performed1stProstate Case Utilizing C-4 MRI Markers1stVeterinary Case With Cs-131***Added to the Russell Microcap Listing

Metastatic Brain Cancer By Cornell Weill

Gynecologic CancerBy University of KentuckyProstate CancerBy University of Pittsburg

Prostate Seeds I-125 & P-103External Beam, Robotic Surgery Brain Cancers and Tumors External Beam, ChemotherapyLung Cancer Seeds I-125External BeamGynecologic Cancer External Bean

Pharma ModelProduct development and pre-human testing: 5 yearsHuman Clinical Trials: 5 yearsFDA Approval: 2 yearsAdoptionIsoRay Prostate ModelProduct development 510(k) FDA Approval 1-2 yearsEarly Adopters DataPublished Papers 5-6 yearsWider Scale AdoptionIsoRay New Product ModelProduct development 510(k) FDA Approval1-2 yearsEarly Adopters DataPublished Papers 2-5 yearsWider Scale Adoption

Thomas Jefferson Head & Neck CancerUPMC Focal Prostate StudyMoran Focal Prostate StudyBarrows Multiple Brain TumorsCornell Weill Lung CancerMD Anderson Prostate CancerSylvestor Dual Therapy Prostate CancerCole Mono Therapy Prostate Cancer

*